FDA Inspection
FujiFilm Diosynth Biotechnologies U.S.A., Inc.FujiFilm Diosynth Biotechnologies U.S.A., Inc. – FDA Inspection, Oct 26, 2018
Record Details
This FDA Inspection record concerns FujiFilm Diosynth Biotechnologies U.S.A., Inc., with an inspection on October 26, 2018, issued by the Atlanta District Office, covering human drugs.
- Inspection Date
- October 26, 2018
- Product Type
- Human Drugs
- Office
- Atlanta District Office
- People
- Amy A. Devlin (Company Rep)
- Ashutosh V. Rao (Issuing Officer)
- Steven Fong (Issuing Officer)
View Company Profile
ID · 6bbe573e-00b9-4c23-89b2-3f0f8cd98bcb
Inspection Facts
- Inspection number
- 1080402
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of FujiFilm Diosynth Biotechnologies U.S.A., Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| March 27, 2026 | Not classified | Atlanta District Office | |
| February 10, 2023 | Not classified | Atlanta District Office | |
| March 1, 2019 | Not classified | Atlanta District Office | |
| February 9, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 31, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for FujiFilm Diosynth Biotechnologies U.S.A., Inc.
- FDA Inspection 1309990 - 2026-03-27
- FDA Inspection 1218019 - 2023-02-10
- FDA Inspection 1092044 - 2019-03-01
- FDA Inspection 1045267 - 2018-02-09
- FDA Inspection 989406 - 2016-03-31
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.